Thrombolytics for Intermediate-Risk Pulmonary Embolisim: Are We There Yet?

In this video, Jay GIri, MD, Director, Peripheral Intervention at Penn Medicine, offers an overview of thrombolytic therapy for pulmonary embolism. Dr Giri’s discussion includes a comparison of thrombolytics to standard anticoagulation therapy, an overview of the PEITHO trial of the tissue plasminogen activator tenecteplase, catheter-directed thrombolysis and age-specific recommendations for each treatment.

 

Related Links


Published

January 7, 2015

Created by

Penn Physician VideoLink